Opening up malaria drug discovery for good
Scientists are exploring new open innovation and open source approaches to catalyze malaria drug development and move us closer to achieving the goal of ending malaria for good.
Sign up to receive news and updates from GHTC.
Scientists are exploring new open innovation and open source approaches to catalyze malaria drug development and move us closer to achieving the goal of ending malaria for good.
October 2016 delivered two sobering wake-up calls: The tuberculosis (TB) epidemic is larger than many realized, and TB R&D has has fallen to its lowest level in seven years.
A new tool from the US Centers for Disease Control and Prevention is helping researchers develop diagnostic tests and antibiotics to combat the growing problem of antibiotic resistance.
Global health advocates traveled to the US Centers for Disease Control and Prevention last month. Here's what they learned about the agency's work.